IRON
Disc Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$81.17
−2.02%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-38.2%
Return on equity
-33.5%
Return on assets
-38.2%
Return on invested capital
0.00x
Asset turnover
-$197.5M
Cash from operations
$16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026